Drug intelligence / Profile preview

glucosamine + chondroitin sulfate + prednisolone + chloroquine

Development stage
Phase 4
Lead developer
Pierre Fabre
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

This is a combination product containing four active ingredients: - **Glucosamine** and **chondroitin sulfate** are naturally occurring compounds commonly used as dietary supplements for the symptomatic management of osteoarthritis and joint pain. Glucosamine is thought to stimulate the formation and repair of articular cartilage, while chondroitin sulfate may inhibit enzymes that degrade cartilage. Both have mild anti-inflammatory effects but their efficacy in osteoarthritis remains controversial, with studies showing mixed results[1][2][3][5]. - **Prednisolone** is a synthetic glucocorticoid corticosteroid with potent anti-inflammatory and immunosuppressive properties. It acts primarily by binding to the glucocorticoid receptor, modulating gene expression to suppress inflammation. - **Chloroquine** is an antimalarial agent also used as a disease-modifying antirheumatic drug (DMARD) in autoimmune diseases such as rheumatoid arthritis. It works by interfering with lysosomal activity and antigen presentation in immune cells. This specific four-drug combination does not appear to be marketed under any unique brand name or widely recognized formulation; it would represent an off-label or compounded therapy potentially aimed at severe inflammatory joint conditions where both symptom relief (glucosamine/chondroitin), immunosuppression (prednisolone), and DMARD action (chloroquine) are desired.

02

Targets

ARSB (N-acetylgalactosamine 4-sulfatase)GR (Glucocorticoid receptor)Neuraminidase

Beyond the preview

Go deeper on glucosamine + chondroitin sulfate + prednisolone + chloroquine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on glucosamine + chondroitin sulfate + prednisolone + chloroquine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call